Mylan Labs

Mylan's Struggles Continue in the First Quarter
Mylan's Struggles Continue in the First Quarter
Motley Fool
Mylan Labs
earnings
Flag link:
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Flag link:
Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment
Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment
Fierce Pharma
Mylan Labs
Pfizer
EpiPens
Flag link:
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Flag link:
Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?
Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?
Fierce Pharma
Merck
Samsung Bioepis
Lantus
insulin
diabetes
biosimilars
Mylan Labs
Biocon
Flag link:
Mylan Pharmaceuticals Pledges to Resolve FDA Citations Over Quality Control Failures
Mylan Pharmaceuticals Pledges to Resolve FDA Citations Over Quality Control Failures
RAPS.org
Mylan Labs
drug manufacturing
FDA
Flag link:
Moody's picks 5 early winners in biosimilar market
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
biosimilars
Pfizer
Biogen
Novartis
Amgen
Mylan Labs
Flag link:
Mylan secretly maneuvered to suppress evidence in EpiPen suit, plaintiffs say
Mylan secretly maneuvered to suppress evidence in EpiPen suit, plaintiffs say
Fierce Pharma
Mylan Labs
Pfizer
EpiPens
Flag link:
Mylan and Novartis to FDA: Where are the Suffixes?
Mylan and Novartis to FDA: Where are the Suffixes?
RAPS.org
Mylan Labs
Novartis
drug names
biosimilars
biologics
Flag link:
Could troubled Mylan swing a sale to private equity buyer? One analyst thinks so
Could troubled Mylan swing a sale to private equity buyer? One analyst thinks so
Fierce Pharma
Mylan Labs
M&A
Flag link:
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
Forbes
AbbVie
Mylan Labs
Fujifilm
biosimilars
Humira
Flag link:
With EpiPen competitors bearing down, can Mylan maintain its lead?
With EpiPen competitors bearing down, can Mylan maintain its lead?
Fierce Pharma
Mylan Labs
EpiPens
ephinephrine autoinjectors
Kaleo
Auvi-Q
Flag link:
Mylan launches generic Brevibloc heart injection
Mylan launches generic Brevibloc heart injection
Drug Delivery Business News
Mylan Labs
generics
Baxter
Brevibloc
Flag link:
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
BioSpace
Mylan Labs
Novartis
cystic fibrosis
Flag link:
EpiPen class action lawsuit against Mylan, Pfizer to continue, judge rules
EpiPen class action lawsuit against Mylan, Pfizer to continue, judge rules
Biopharma Dive
Pfizer
Mylan Labs
generics
EpiPens
antitrust
Flag link:
Mylan to explore its options as North American business struggles
Mylan to explore its options as North American business struggles
Biopharma Dive
Mylan Labs
Flag link:
Mylan lowers outlook after Q2 earnings, sales miss estimates
Mylan lowers outlook after Q2 earnings, sales miss estimates
Drug Delivery Business News
Mylan Labs
earnings
Flag link:
Pfizer says shortage of adult-dose EpiPens in Canada will persist through August
Pfizer says shortage of adult-dose EpiPens in Canada will persist through August
Fierce Pharma
EpiPens
Mylan Labs
Pfizer
drug shortage
drug manufacturing
Flag link:
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Fierce Pharma
Mylan Labs
Copaxone
generics
Teva Pharmaceuticals
MS
drug pricing
Flag link:
Mylan plant slapped with 32-page FDA Form 483
Mylan plant slapped with 32-page FDA Form 483
Fierce Pharma
Mylan Labs
FDA
drug manufacturing
Flag link:

Pages